Filing Flows › Boston Scientific (BSX) › Free cash flow
Boston Scientific (BSX) free cash flow by quarter
Boston Scientific's free cash flow was $868M in Q3 2026 (third quarter 2026), -32% from Q2 2026. Over the last 7 quarters it ranged from $171M (Q1 2026) to $1.3B (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $868M | -32% | -25% |
| Q2 2026 | $1.3B | +648% | +13% |
| Q1 2026 | $171M | -83% | -52% |
| Q4 2025 | $1.0B | -13% | — |
| Q3 2025 | $1.2B | +3% | — |
| Q2 2025 | $1.1B | +219% | — |
| Q1 2025 | $354M | — | — |
Q3 2026 at a glance
Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Boston Scientific's free cash flow?
Boston Scientific's free cash flow was $868M in Q3 2026 (third quarter 2026), -32% from Q2 2026.
How has Boston Scientific's free cash flow changed?
Over the last 7 quarters it ranged from $171M (Q1 2026) to $1.3B (Q2 2026).